Martha Rocio Hernández Preciado

Dr. Martha Rocio Hernández Preciado

Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2019 in Genetic Testing and Molecular Biomarkers
Verified
Journal Article
Open access
MPMartha Rocio Hernández Preciado
Martha Rocio Hernández Preciado
María Cristina Morán MoguelMaría Cristina Morán Moguel
María Cristina Morán Moguel
IDIngrid Patricia Dávalos-Rodríguez
Ingrid Patricia Dávalos-Rodríguez
CEChristian Michel Enríquez-Barajas
Christian Michel Enríquez-Barajas
JVJuan Paulo Valdovinos-Maravilla
Juan Paulo Valdovinos-Maravilla
Mario Salazar ParamoMario Salazar Paramo
Mario Salazar Paramo
Aim: The present study looked for variation in the miRNA-24 sequence, and evaluated the associations between the dihydrofolate reductase ( DHFR ) gene-829 C-T polymorphism and plasma DHFR concentrations with response to methotrexate (MTX) treatment in Mexican patients with rheumatoid arthritis (RA). Methods: A total of 135 women with RA were classified as responders (disease activity score [DAS28] 3.2). We determined the genotype of the patients using the polymerase chain reaction-restriction fragment length polymorphism method. Plasma DHFR enzyme levels and mi-RNA24 sequences were assessed by enzyme-linked immunosorbent assay (ELISA) and Sanger sequencing, respectively. Allelic frequencies and the genotypic distribution of the polymorphism were analyzed by the chi-square test. Results: The genotype frequencies of the DHFR −829C-T polymorphism among responders were 37.0% CC, 52.1% CT, and 10.9% TT and for nonresponders were 33.9% CC, 56.4% CT, and 9.7% TT. No significant differences in genotype frequencies were found between the groups ( p = 0.88). The DHFR levels relative to genotype for responders were 6.8 ± 2.7, 6.1 ± 2.7, and 6.5 ± 1.5 ng/mL for CC, CT, and TT, respectively, and for nonresponders were 6.5 ± 2.0, 6.1 ± 3.1, and 7.4 ± 1.8 ng/mL for CC, CT, and TT, respectively. No significant differences were found between the two groups. Similarly, both groups showed no sequence variations in miRNA-24 gene. Conclusion: The −829C-T polymorphism of DHFR gene was not associated with response to MTX by RA patients, and no variations were found in the miRNA-24 sequence that might modify the response to treatment or DHFR enzyme levels in a Mexican population with RA.

Verified
Journal Article
Open access
PDF file
MPMartha Rocio Hernández Preciado
Martha Rocio Hernández Preciado
JMJazmin Marquez-Pedroza
Jazmin Marquez-Pedroza
NRNayeli Alejandra Sánchez Rosales
Nayeli Alejandra Sánchez Rosales
JRJOSE DE JESUS GARCIA RIVERA
JOSE DE JESUS GARCIA RIVERA
AKAntonio Kobayashi-Gutiérrez
Antonio Kobayashi-Gutiérrez
MMMario Alberto Mireles-Ramírez
Mario Alberto Mireles-Ramírez
The objective of this study was to evaluate the clinical files of patients with RRMS who started rituximab (RTX) compared with a second-line treatment (natalizumab (NTZ) or fingolimod (FTY)). This was a historical cohort study. We compared the effect according to the Expanded Disability Status Scale (EDSS) and the number of relapses in RRMS patients receiving these treatments after a mean period of 12 months. We found a statistically significant difference (p < 0.001) when comparing the EDSS scores and the annual relapse rates of patients receiving RTX with those receiving NTZ or FTY. This study is essential for our clinical practice, since patients with limited treatment options represent a challenge with regard to the management of their medical care. However, clinical trials and prospective studies with long follow-up periods are necessary to provide sufficient evidence on the efficacy of RTX and thus include this treatment in the therapeutic profile of patients with MS.

Verified
Journal Article
Open access
PDF file
ACAna Luisa Corona-Nakamura
Ana Luisa Corona-Nakamura
MAMartha Judith Arias-Merino
Martha Judith Arias-Merino
Guadalupe Miranda-NovalesGuadalupe Miranda-Novales
Guadalupe Miranda-Novales
DNDavid Nava-Jiménez
David Nava-Jiménez
JDJuan Antonio Delgado-Vázquez
Juan Antonio Delgado-Vázquez
MMMario Alberto Mireles-Ramírez
Mario Alberto Mireles-Ramírez
Neurotuberculosis (neuroTB) is a devastating disease, and is difficult to diagnose. The aim of this study was to analyze the clinical and imaging characteristics, and outcomes of a retrospective cohort (2000–2022) of hospitalized patients diagnosed with intraspinal and intracranial neuroTB. This work was designed through clinical, laboratory and imaging findings. Variables included: demographic data, history of tuberculosis, neurological complications, comorbidities and outcomes. Morbi-mortality risk factors were identified by univariate analysis. The cohort included: 103 patients with intraspinal and 82 with intracranial neuroTB. During the study period, in-hospital mortality of 3% for intraspinal and 29.6% for intracranial neuroTB was estimated. Motor deficit was found in all patients with intraspinal neuroTB. Risk factors for the unfavorable outcome of patients with intraspinal neuroTB were: age ≥ 40 years, diabetes mellitus (DM), diagnostic delay, kyphosis and spondylodiscitis ≥ 3 levels of involvement. Among the patients with intracranial neuroTB, 79/82 (96.3%) had meningitis and 22 patients had HIV infection (10 of them died). Risk factors for mortality from intracranial neuroTB were: HIV infection, hydrocephalus, stroke, lymphopenia and disseminated and gastrointestinal TB. Patients with intraspinal neuroTB had a significant number of destroyed vertebrae that determined their neurological deficit status. The mortality burden in intracranial neuroTB was conditioned by HIV infection and renal transplantation patients.

15 May 2025 in NeuroRehabilitation
Verified
Journal Article
Closed access
TVTeresita J Villaseñor-Cabrera
Teresita J Villaseñor-Cabrera
KSKaren Anette Sanchez-Jacuinde
Karen Anette Sanchez-Jacuinde
MJMiriam E Jiménez-Maldonado
Miriam E Jiménez-Maldonado
APAlejandra Morlett Paredes
Alejandra Morlett Paredes
ELEnrique López
Enrique López
EVEdgar Ricardo Valdivia-Tangarife
Edgar Ricardo Valdivia-Tangarife
Background: The Perri Auditory Verbal Learning Test (Perri-AVLT) is a cognitive tool that is used to assess verbal learning and memory. To date, demographically adjusted norms for Perri-AVLT have not been identified for Mexican adults. Objectives: This study aimed to 1) estimate the means, standard deviations, and ranges for Perri-AVLT raw scores, 2) develop regression-based norms from healthy participants to enable demographic adjustments for clinical interpretation, and 3) assess test-retest reliability. Methods: The sample included 430 participants (380 cognitively normal individuals and 50 clinical cases) aged 18–59 years from Mexico (Jalisco, Guanajuato and Mexico City). The participants completed the Perri-AVLT. A multivariate regression-based norming approach was used to evaluate the effects of age, sex, and years of education on test performance. Results: Healthy participants aged ≤ 39 years performed significantly better than those aged ≥ 40 years did in all the Perri-AVLT trials. Age and years of education were significant predictors of performance, with older age associated with lower scores and more years of education associated with greater word recall on the Perri-AVLT. Conclusion: We provided normative data for the Perri-AVLT after performing regression analyses adjusted for sociodemographic factors. These norms can be used to evaluate verbal learning and memory in early-to-midlife Mexican adults. This information can support neuropsychologists in the context of cognitive assessment, rehabilitation and research.

Verified
Journal Article
Open access
PDF file
JMJazmin Marquez-Pedroza
Jazmin Marquez-Pedroza
MPMartha Rocio Hernández Preciado
Martha Rocio Hernández Preciado
EVEdgar Ricardo Valdivia-Tangarife
Edgar Ricardo Valdivia-Tangarife
FAFrancisco Javier Alvarez-Padilla
Francisco Javier Alvarez-Padilla
MMMario Alberto Mireles-Ramírez
Mario Alberto Mireles-Ramírez
BTBlanca Miriam Torres-Mendoza
Blanca Miriam Torres-Mendoza
Multiple sclerosis (MS) is a common disease in young women of reproductive age, characterized by demyelination of the central nervous system (CNS). Understanding how genes related to MS are expressed during pregnancy can provide insights into the potential mechanisms by which pregnancy affects the course of this disease. This review article presents evidence-based studies on these patients’ gene expression patterns. In addition, it constructs interaction networks using bioinformatics tools, such as STRING and KEGG pathways, to understand the molecular role of each of these genes. Bioinformatics research identified 25 genes and 21 signaling pathways, which allows us to understand pregnancy patients’ genetic and biological phenomena and formulate new questions about MS during pregnancy.

1 June 2026
Verified
Journal Article
Open access
PDF file
MMMario Alberto Mireles-Ramírez
Mario Alberto Mireles-Ramírez
JGJ. Ahuixotl Gutierrez-Aceves
J. Ahuixotl Gutierrez-Aceves
BCBetsabe Contreras-Haro
Betsabe Contreras-Haro
MEMaría Claudia Espinel-Bermúdez
María Claudia Espinel-Bermúdez
DHDaniel Hernandez-Gordillo
Daniel Hernandez-Gordillo
MPMartha Rocio Hernández Preciado
Martha Rocio Hernández Preciado
Resumen La educación médica tiene como eje fundamental la generación de habilidades para la atención de precisión a los pacientes; sin embargo, una de las herramientas esenciales para la reflexión médica en cada caso radica, también, en el desarrollo de habilidades científicas que permitan al médico generar un pensamiento crítico y ofrecer nuevas alternativas basadas en la evidencia. No obstante, existen barreras importantes que dificultan que el proceso de formación en investigación permee las habilidades del médico. Los hospitales escuela requieren reflexionar acerca de las barreras modificables, con el fin de ofrecer a los médicos en formación un ambiente propicio y motivador hacia la ciencia. El presente artículo se fundamenta en la reflexión de estudios científicos que versan sobre las dificultades para la incorporación de habilidades en investigación.